| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.20e-16 | 100 | 87 | 13 | GO:0030527 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2BC12L IL12A H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 APP H2BC12 H2BC18 | 1.71e-10 | 398 | 87 | 15 | GO:0046982 |
| GeneOntologyMolecularFunction | protein dimerization activity | H2BC12L IL12A H2BC11 AHRR H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MTMR1 H2BC5 H2BC3 APP KIF20B H2BC12 H2BC18 FBXW11 | 8.11e-07 | 1205 | 87 | 19 | GO:0046983 |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 2.64e-05 | 134 | 87 | 6 | GO:0003697 | |
| GeneOntologyMolecularFunction | structural molecule activity | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 OTOG | 2.91e-05 | 891 | 87 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | protein kinase activator activity | 4.79e-05 | 149 | 87 | 6 | GO:0030295 | |
| GeneOntologyMolecularFunction | kinase activator activity | 6.88e-05 | 159 | 87 | 6 | GO:0019209 | |
| GeneOntologyMolecularFunction | histone H3K9me/H3K9me2 demethylase activity | 1.86e-04 | 5 | 87 | 2 | GO:0140683 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 3.75e-04 | 78 | 87 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | tubulin binding | 5.56e-04 | 428 | 87 | 8 | GO:0015631 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 9.44e-04 | 259 | 87 | 6 | GO:0019887 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 1.01e-03 | 11 | 87 | 2 | GO:0052629 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 1.01e-03 | 11 | 87 | 2 | GO:0004143 | |
| GeneOntologyMolecularFunction | STAT family protein binding | 1.42e-03 | 13 | 87 | 2 | GO:0097677 | |
| GeneOntologyMolecularFunction | single-stranded telomeric DNA binding | 1.42e-03 | 13 | 87 | 2 | GO:0043047 | |
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 1.65e-03 | 14 | 87 | 2 | GO:0032454 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 1.65e-03 | 14 | 87 | 2 | GO:0004438 | |
| GeneOntologyMolecularFunction | transition metal ion binding | KDM3A ZCCHC9 MELTF ATP7A BRCA1 ACO2 ADAMTS20 ZNF208 PRKN LTF APP ZMAT1 PTGR3 | 1.86e-03 | 1189 | 87 | 13 | GO:0046914 |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 1.90e-03 | 15 | 87 | 2 | GO:0052744 | |
| GeneOntologyMolecularFunction | sequence-specific single stranded DNA binding | 1.90e-03 | 15 | 87 | 2 | GO:0098847 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 2.16e-03 | 16 | 87 | 2 | GO:0106018 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 2.17e-03 | 305 | 87 | 6 | GO:0019207 | |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 2.49e-11 | 30 | 83 | 7 | GO:0002227 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2BC11 KDM3A H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 BRCA2 H2BC3 TEX15 APP TDRD1 RAD54L HR RAD50 | 6.78e-10 | 741 | 83 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | mucosal immune response | 8.51e-10 | 48 | 83 | 7 | GO:0002385 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 1.50e-09 | 122 | 83 | 9 | GO:0006334 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 1.82e-09 | 85 | 83 | 8 | GO:0019731 | |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 2.01e-09 | 54 | 83 | 7 | GO:0002251 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 5.74e-09 | 142 | 83 | 9 | GO:0034728 | |
| GeneOntologyBiologicalProcess | chromatin organization | H2BC11 KDM3A H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 BRCA2 H2BC3 TEX15 APP TDRD1 RAD54L HR RAD50 | 1.33e-08 | 896 | 83 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 6.74e-08 | 134 | 83 | 8 | GO:0061844 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H2BC11 KDM3A H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 BRCA2 H2BC3 TEX15 APP TDRD1 RAD54L HR RAD50 | 6.98e-08 | 999 | 83 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 1.61e-07 | 150 | 83 | 8 | GO:0050830 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 7.12e-07 | 249 | 83 | 9 | GO:0065004 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 8.33e-07 | 186 | 83 | 8 | GO:0019730 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 6.18e-06 | 324 | 83 | 9 | GO:0006302 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 1.08e-05 | 188 | 83 | 7 | GO:0000724 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 1.15e-05 | 350 | 83 | 9 | GO:0051321 | |
| GeneOntologyBiologicalProcess | homologous recombination | 1.21e-05 | 74 | 83 | 5 | GO:0035825 | |
| GeneOntologyBiologicalProcess | recombinational repair | 1.33e-05 | 194 | 83 | 7 | GO:0000725 | |
| GeneOntologyBiologicalProcess | DNA recombination | 1.71e-05 | 368 | 83 | 9 | GO:0006310 | |
| GeneOntologyBiologicalProcess | meiosis I | 2.84e-05 | 147 | 83 | 6 | GO:0007127 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 3.62e-05 | 405 | 83 | 9 | GO:0042742 | |
| GeneOntologyBiologicalProcess | meiosis I cell cycle process | 3.83e-05 | 155 | 83 | 6 | GO:0061982 | |
| GeneOntologyBiologicalProcess | humoral immune response | 4.52e-05 | 321 | 83 | 8 | GO:0006959 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 5.18e-05 | 240 | 83 | 7 | GO:0140013 | |
| GeneOntologyBiologicalProcess | response to bacterium | H2BC12L IL12A H2BC11 H2BC13 H2BC4 H2BC21 CD80 MLH1 LTF APP LYST CNR1 H2BC12 | 7.11e-05 | 916 | 83 | 13 | GO:0009617 |
| GeneOntologyBiologicalProcess | response to manganese ion | 7.93e-05 | 21 | 83 | 3 | GO:0010042 | |
| GeneOntologyBiologicalProcess | piRNA processing | 9.16e-05 | 22 | 83 | 3 | GO:0034587 | |
| GeneOntologyBiologicalProcess | mitotic G2/M transition checkpoint | 9.37e-05 | 59 | 83 | 4 | GO:0044818 | |
| GeneOntologyBiologicalProcess | organelle fission | ANKRD31 TDRKH BRCA2 MLH1 PRKN TEX15 STAG2 KIF20B RAD54L RAD50 | 9.68e-05 | 571 | 83 | 10 | GO:0048285 |
| GeneOntologyBiologicalProcess | male meiotic nuclear division | 1.00e-04 | 60 | 83 | 4 | GO:0007140 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 1.03e-04 | 268 | 83 | 7 | GO:1903046 | |
| GeneOntologyBiologicalProcess | regulation of G2/M transition of mitotic cell cycle | 1.06e-04 | 116 | 83 | 5 | GO:0010389 | |
| GeneOntologyBiologicalProcess | defense response to Gram-negative bacterium | 1.19e-04 | 119 | 83 | 5 | GO:0050829 | |
| GeneOntologyBiologicalProcess | reciprocal meiotic recombination | 1.54e-04 | 67 | 83 | 4 | GO:0007131 | |
| GeneOntologyBiologicalProcess | reciprocal homologous recombination | 1.54e-04 | 67 | 83 | 4 | GO:0140527 | |
| GeneOntologyBiologicalProcess | regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway | 1.59e-04 | 5 | 83 | 2 | GO:1903381 | |
| GeneOntologyBiologicalProcess | meiotic metaphase I homologous chromosome alignment | 1.59e-04 | 5 | 83 | 2 | GO:0043060 | |
| GeneOntologyBiologicalProcess | mitotic recombination | 1.71e-04 | 27 | 83 | 3 | GO:0006312 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G2/M phase transition | 1.87e-04 | 131 | 83 | 5 | GO:1902749 | |
| GeneOntologyBiologicalProcess | nuclear division | 2.15e-04 | 512 | 83 | 9 | GO:0000280 | |
| GeneOntologyBiologicalProcess | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 2.37e-04 | 6 | 83 | 2 | GO:0036483 | |
| GeneOntologyBiologicalProcess | meiotic metaphase chromosome alignment | 2.37e-04 | 6 | 83 | 2 | GO:0051311 | |
| GeneOntologyBiologicalProcess | chromosome organization involved in meiotic cell cycle | 2.38e-04 | 75 | 83 | 4 | GO:0070192 | |
| GeneOntologyBiologicalProcess | negative regulation of G2/M transition of mitotic cell cycle | 2.38e-04 | 75 | 83 | 4 | GO:0010972 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle G2/M phase transition | 2.64e-04 | 77 | 83 | 4 | GO:1902750 | |
| GeneOntologyBiologicalProcess | homologous chromosome segregation | 2.77e-04 | 78 | 83 | 4 | GO:0045143 | |
| GeneOntologyBiologicalProcess | P granule organization | 3.32e-04 | 7 | 83 | 2 | GO:0030719 | |
| GeneOntologyBiologicalProcess | maternal determination of anterior/posterior axis, embryo | 3.32e-04 | 7 | 83 | 2 | GO:0008358 | |
| GeneOntologyBiologicalProcess | pole plasm assembly | 3.32e-04 | 7 | 83 | 2 | GO:0007315 | |
| GeneOntologyBiologicalProcess | oocyte anterior/posterior axis specification | 3.32e-04 | 7 | 83 | 2 | GO:0007314 | |
| GeneOntologyBiologicalProcess | regulation of spontaneous synaptic transmission | 3.32e-04 | 7 | 83 | 2 | GO:0150003 | |
| GeneOntologyBiologicalProcess | response to ionizing radiation | 3.61e-04 | 151 | 83 | 5 | GO:0010212 | |
| GeneOntologyBiologicalProcess | neuron cellular homeostasis | 3.68e-04 | 84 | 83 | 4 | GO:0070050 | |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 3.72e-04 | 152 | 83 | 5 | GO:0000086 | |
| GeneOntologyBiologicalProcess | regulation of mitotic recombination | 4.41e-04 | 8 | 83 | 2 | GO:0000019 | |
| GeneOntologyBiologicalProcess | oocyte construction | 5.65e-04 | 9 | 83 | 2 | GO:0007308 | |
| GeneOntologyBiologicalProcess | oocyte axis specification | 5.65e-04 | 9 | 83 | 2 | GO:0007309 | |
| GeneOntologyBiologicalProcess | cell cycle process | ANKRD31 TDRKH BRCA1 BRCA2 NABP2 MLH1 TEX15 NABP1 APP STAG2 KIF20B RAD54L FBXW11 AZIN1 RAD50 | 5.73e-04 | 1441 | 83 | 15 | GO:0022402 |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 6.36e-04 | 171 | 83 | 5 | GO:0044839 | |
| GeneOntologyBiologicalProcess | DNA strand resection involved in replication fork processing | 7.05e-04 | 10 | 83 | 2 | GO:0110025 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 8.42e-04 | 46 | 83 | 3 | GO:0010526 | |
| GeneOntologyBiologicalProcess | antifungal humoral response | 8.59e-04 | 11 | 83 | 2 | GO:0019732 | |
| GeneOntologyBiologicalProcess | lipid phosphorylation | 8.59e-04 | 11 | 83 | 2 | GO:0046834 | |
| GeneOntologyBiologicalProcess | retrotransposition | 9.54e-04 | 48 | 83 | 3 | GO:0032197 | |
| GeneOntologyBiologicalProcess | cellular response to manganese ion | 1.03e-03 | 12 | 83 | 2 | GO:0071287 | |
| GeneOntologyBiologicalProcess | transposition | 1.07e-03 | 50 | 83 | 3 | GO:0032196 | |
| GeneOntologyBiologicalProcess | DNA repair | 1.17e-03 | 648 | 83 | 9 | GO:0006281 | |
| GeneOntologyBiologicalProcess | replication fork processing | 1.20e-03 | 52 | 83 | 3 | GO:0031297 | |
| GeneOntologyCellularComponent | nucleosome | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.72e-14 | 138 | 87 | 13 | GO:0000786 |
| GeneOntologyCellularComponent | chromatin | H2BC12L ANKRD31 H2BC11 KDM3A AHRR H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 STAG2 H2BC12 H2BC18 HR RAD50 | 8.48e-06 | 1480 | 87 | 19 | GO:0000785 |
| GeneOntologyCellularComponent | SOSS complex | 1.02e-04 | 4 | 87 | 2 | GO:0070876 | |
| GeneOntologyCellularComponent | BRCA1-C complex | 2.54e-04 | 6 | 87 | 2 | GO:0070533 | |
| GeneOntologyCellularComponent | chromosomal region | 3.69e-04 | 421 | 87 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 5.68e-04 | 91 | 87 | 4 | GO:0000794 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic density membrane | 7.54e-04 | 10 | 87 | 2 | GO:0099147 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 8.46e-04 | 176 | 87 | 5 | GO:0000781 | |
| GeneOntologyCellularComponent | pi-body | 9.19e-04 | 11 | 87 | 2 | GO:0071546 | |
| GeneOntologyCellularComponent | synaptonemal complex | 9.29e-04 | 46 | 87 | 3 | GO:0000795 | |
| GeneOntologyCellularComponent | synaptonemal structure | 9.29e-04 | 46 | 87 | 3 | GO:0099086 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic specialization membrane | 1.10e-03 | 12 | 87 | 2 | GO:0098892 | |
| GeneOntologyCellularComponent | axon | SLC12A6 NRG1 ATP7A TRPM7 KIF21A DGKI PRKN APP KIF20B CNR1 FBXW11 | 1.15e-03 | 891 | 87 | 11 | GO:0030424 |
| HumanPheno | Cranial nerve paralysis | SLC12A6 IL12A BRCA1 BRCA2 PYROXD1 ASAH1 MTM1 VPS41 LYST STAG2 | 7.31e-06 | 329 | 29 | 10 | HP:0006824 |
| HumanPheno | Abnormal cranial nerve physiology | SLC12A6 IL12A BRCA1 BRCA2 PYROXD1 ASAH1 MTM1 VPS41 LYST STAG2 | 7.93e-06 | 332 | 29 | 10 | HP:0031910 |
| HumanPheno | Abnormal cranial nerve morphology | SLC12A6 IL12A BRCA1 BRCA2 PYROXD1 ASAH1 MTM1 VPS41 LYST STAG2 | 2.33e-05 | 375 | 29 | 10 | HP:0001291 |
| HumanPheno | Breast carcinoma | 3.15e-05 | 67 | 29 | 5 | HP:0003002 | |
| HumanPheno | Tumours of the breast | 4.78e-05 | 73 | 29 | 5 | HP:0010623 | |
| HumanPheno | Primary peritoneal carcinoma | 5.79e-05 | 14 | 29 | 3 | HP:0030406 | |
| HumanPheno | Abnormality of the peripheral nervous system | SLC12A6 IL12A ATP7A BRCA1 SBF1 BRCA2 ZNF423 KIF21A MTM1 PRKN LYST STAG2 | 6.57e-05 | 617 | 29 | 12 | HP:0410008 |
| HumanPheno | Neoplasm of the breast | 1.45e-04 | 92 | 29 | 5 | HP:0100013 | |
| MousePheno | abnormal double-strand DNA break repair | 1.02e-05 | 70 | 58 | 5 | MP:0010948 | |
| MousePheno | abnormal skin pigmentation | 2.94e-05 | 87 | 58 | 5 | MP:0002095 | |
| MousePheno | small gonad | ANKRD31 KDM3A TDRKH TXNDC5 BRCA1 SBF1 BRCA2 ASAH1 MLH1 TEX15 NABP1 TDRD1 RAD50 | 5.28e-05 | 885 | 58 | 13 | MP:0001116 |
| MousePheno | abnormal intracellular organelle physiology | 5.89e-05 | 532 | 58 | 10 | MP:0014241 | |
| MousePheno | abnormal primary sex determination | ANKRD31 KDM3A TDRKH TXNDC5 BRCA1 SBF1 BRCA2 ASAH1 MLH1 TEX15 NABP1 TDRD1 RAD50 | 6.35e-05 | 901 | 58 | 13 | MP:0002211 |
| MousePheno | azoospermia | 6.38e-05 | 244 | 58 | 7 | MP:0005159 | |
| MousePheno | increased T cell derived lymphoma incidence | 6.71e-05 | 53 | 58 | 4 | MP:0002024 | |
| MousePheno | increased thymus tumor incidence | 7.23e-05 | 54 | 58 | 4 | MP:0010365 | |
| MousePheno | absent gametes | 8.63e-05 | 256 | 58 | 7 | MP:0001117 | |
| MousePheno | abnormal sex determination | ANKRD31 KDM3A TDRKH TXNDC5 BRCA1 SBF1 BRCA2 ASAH1 MLH1 TEX15 NABP1 TDRD1 RAD50 | 1.03e-04 | 945 | 58 | 13 | MP:0002210 |
| MousePheno | small testis | ANKRD31 KDM3A TDRKH TXNDC5 BRCA1 SBF1 BRCA2 MLH1 TEX15 NABP1 TDRD1 RAD50 | 1.16e-04 | 823 | 58 | 12 | MP:0001147 |
| MousePheno | abnormal susceptibility to induced morbidity/mortality | 1.27e-04 | 471 | 58 | 9 | MP:0020148 | |
| MousePheno | increased hemolymphoid system tumor incidence | 1.35e-04 | 191 | 58 | 6 | MP:0010296 | |
| MousePheno | abnormal DNA repair | 1.99e-04 | 130 | 58 | 5 | MP:0008058 | |
| MousePheno | neoplasm | 2.14e-04 | 747 | 58 | 11 | MP:0002006 | |
| MousePheno | increased susceptibility to xenobiotic induced morbidity/mortality | 2.21e-04 | 133 | 58 | 5 | MP:0009766 | |
| MousePheno | abnormal tumor incidence | 2.52e-04 | 635 | 58 | 10 | MP:0002019 | |
| MousePheno | abnormal tumor susceptibility | 3.04e-04 | 650 | 58 | 10 | MP:0002166 | |
| MousePheno | increased tumor incidence | 3.07e-04 | 530 | 58 | 9 | MP:0002020 | |
| MousePheno | abnormal testis size | ANKRD31 KDM3A TDRKH TXNDC5 BRCA1 SBF1 BRCA2 MLH1 TEX15 NABP1 TDRD1 RAD50 | 3.11e-04 | 915 | 58 | 12 | MP:0004849 |
| MousePheno | centrally nucleated skeletal muscle fibers | 3.34e-04 | 80 | 58 | 4 | MP:0009404 | |
| MousePheno | limp posture | 3.51e-04 | 7 | 58 | 2 | MP:0001506 | |
| MousePheno | abnormal physiological response to xenobiotic | 3.52e-04 | 662 | 58 | 10 | MP:0008872 | |
| MousePheno | abnormal intracellular organelle morphology | 3.82e-04 | 546 | 58 | 9 | MP:0014239 | |
| MousePheno | abnormal testis morphology | ANKRD31 KDM3A TDRKH TXNDC5 BRCA1 SBF1 BRCA2 ZNF644 MLH1 TEX15 NABP1 TDRD1 RAD50 | 3.91e-04 | 1081 | 58 | 13 | MP:0001146 |
| MousePheno | arrest of spermatogenesis | 4.52e-04 | 239 | 58 | 6 | MP:0001155 | |
| MousePheno | abnormal depression-related behavior | 4.62e-04 | 156 | 58 | 5 | MP:0003360 | |
| MousePheno | decreased small intestinal villus height | 4.66e-04 | 8 | 58 | 2 | MP:0014082 | |
| MousePheno | hindlimb paresis | 4.76e-04 | 37 | 58 | 3 | MP:0031204 | |
| MousePheno | increased susceptibility to induced morbidity/mortality | 5.44e-04 | 346 | 58 | 7 | MP:0009763 | |
| MousePheno | increased lymphoma incidence | 5.80e-04 | 164 | 58 | 5 | MP:0012431 | |
| MousePheno | abnormal hair follicle melanin granule morphology | 5.98e-04 | 9 | 58 | 2 | MP:0005072 | |
| MousePheno | abnormal induced cell death | 6.49e-04 | 256 | 58 | 6 | MP:0008942 | |
| MousePheno | abnormal xenobiotic induced morbidity/mortality | 7.01e-04 | 171 | 58 | 5 | MP:0009765 | |
| MousePheno | abnormal locomotor coordination | 7.26e-04 | 726 | 58 | 10 | MP:0003312 | |
| MousePheno | abnormal cerebral hemisphere morphology | 7.46e-04 | 599 | 58 | 9 | MP:0008540 | |
| MousePheno | abnormal melanosome morphology | 7.96e-04 | 44 | 58 | 3 | MP:0005075 | |
| MousePheno | small ovary | 8.40e-04 | 178 | 58 | 5 | MP:0001127 | |
| MousePheno | abnormal incidence of induced tumors | 8.40e-04 | 269 | 58 | 6 | MP:0013151 | |
| MousePheno | abnormal male reproductive system physiology | PRSS54 ANKRD31 KDM3A TDRKH ATP7A BRCA1 SBF1 BRCA2 MTM1 MLH1 TEX15 TDRD1 CNR1 RAD50 | 8.54e-04 | 1329 | 58 | 14 | MP:0003698 |
| MousePheno | wavy vibrissae | 9.08e-04 | 11 | 58 | 2 | MP:0001279 | |
| MousePheno | abnormal skin coloration | 9.28e-04 | 182 | 58 | 5 | MP:0011239 | |
| MousePheno | infertility | ANKRD31 SLC12A6 KDM3A TDRKH ATP7A BRCA1 SBF1 BRCA2 MLH1 TEX15 TDRD1 HR RAD50 | 9.56e-04 | 1188 | 58 | 13 | MP:0001924 |
| MousePheno | increased sensitivity to induced cell death | 9.75e-04 | 184 | 58 | 5 | MP:0008943 | |
| MousePheno | abnormal sperm number | 9.97e-04 | 624 | 58 | 9 | MP:0002673 | |
| MousePheno | premature death | ATP7A BRCA2 ASAH1 ZNF423 MTM1 NABP2 MLH1 PRKN APP CNR1 HR RAD50 | 1.08e-03 | 1051 | 58 | 12 | MP:0002083 |
| MousePheno | abnormal spermatogenesis | PRSS54 ANKRD31 KDM3A TDRKH BRCA1 SBF1 BRCA2 MLH1 TEX15 TDRD1 RAD50 | 1.13e-03 | 910 | 58 | 11 | MP:0001156 |
| Domain | H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.36e-24 | 21 | 83 | 12 | SM00427 |
| Domain | HISTONE_H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.36e-24 | 21 | 83 | 12 | PS00357 |
| Domain | Histone_H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.36e-24 | 21 | 83 | 12 | IPR000558 |
| Domain | Histone | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.24e-17 | 56 | 83 | 12 | PF00125 |
| Domain | Histone_H2A/H2B/H3 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.24e-17 | 56 | 83 | 12 | IPR007125 |
| Domain | Histone-fold | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.95e-15 | 83 | 83 | 12 | IPR009072 |
| Domain | - | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 9.95e-15 | 69 | 83 | 11 | 1.10.20.10 |
| Domain | Myotubularin-like_Pase_dom | 2.97e-05 | 14 | 83 | 3 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 2.97e-05 | 14 | 83 | 3 | PS51339 | |
| Domain | Myotubularin_fam | 2.97e-05 | 14 | 83 | 3 | IPR030564 | |
| Domain | Myotub-related | 2.97e-05 | 14 | 83 | 3 | PF06602 | |
| Domain | GRAM | 4.55e-05 | 16 | 83 | 3 | SM00568 | |
| Domain | TRANSFERRIN_LIKE_1 | 5.84e-05 | 3 | 83 | 2 | PS00205 | |
| Domain | TRANSFERRIN_LIKE_2 | 5.84e-05 | 3 | 83 | 2 | PS00206 | |
| Domain | TRANSFERRIN_LIKE_3 | 5.84e-05 | 3 | 83 | 2 | PS00207 | |
| Domain | Transferrin_Fe_BS | 5.84e-05 | 3 | 83 | 2 | IPR018195 | |
| Domain | Transferrin | 5.84e-05 | 3 | 83 | 2 | PF00405 | |
| Domain | Transferrin | 5.84e-05 | 3 | 83 | 2 | IPR016357 | |
| Domain | TR_FER | 5.84e-05 | 3 | 83 | 2 | SM00094 | |
| Domain | Transferrin-like_dom | 5.84e-05 | 3 | 83 | 2 | IPR001156 | |
| Domain | TRANSFERRIN_LIKE_4 | 5.84e-05 | 3 | 83 | 2 | PS51408 | |
| Domain | GRAM | 1.23e-04 | 22 | 83 | 3 | PF02893 | |
| Domain | GRAM | 1.23e-04 | 22 | 83 | 3 | IPR004182 | |
| Domain | Copine | 6.88e-04 | 9 | 83 | 2 | PF07002 | |
| Domain | Copine | 6.88e-04 | 9 | 83 | 2 | IPR010734 | |
| Domain | DAGK_acc | 8.58e-04 | 10 | 83 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 8.58e-04 | 10 | 83 | 2 | IPR000756 | |
| Domain | DAGKa | 8.58e-04 | 10 | 83 | 2 | SM00045 | |
| Domain | tRNA_anti-codon | 1.25e-03 | 12 | 83 | 2 | PF01336 | |
| Domain | NA-bd_OB_tRNA | 1.25e-03 | 12 | 83 | 2 | IPR004365 | |
| Domain | TUDOR | 1.72e-03 | 14 | 83 | 2 | PF00567 | |
| Domain | DAGKc | 1.72e-03 | 14 | 83 | 2 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.97e-03 | 15 | 83 | 2 | IPR001206 | |
| Domain | DAGK_cat | 1.97e-03 | 15 | 83 | 2 | PF00781 | |
| Domain | DAGK | 1.97e-03 | 15 | 83 | 2 | PS50146 | |
| Domain | NAD/diacylglycerol_kinase | 2.54e-03 | 17 | 83 | 2 | IPR016064 | |
| Domain | zf-C2H2_6 | 2.75e-03 | 314 | 83 | 6 | PF13912 | |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 BRCA2 MLH1 H2BC5 H2BC3 TEX15 H2BC12 RAD50 | 6.69e-23 | 88 | 72 | 17 | M1011 |
| Pathway | REACTOME_MEIOSIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 BRCA2 MLH1 H2BC5 H2BC3 TEX15 STAG2 H2BC12 RAD50 | 4.15e-22 | 120 | 72 | 18 | M529 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 PPP5C H2BC5 H2BC3 H2BC12 RAD50 | 3.03e-20 | 78 | 72 | 15 | M27589 |
| Pathway | REACTOME_REPRODUCTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 BRCA2 MLH1 H2BC5 H2BC3 TEX15 STAG2 H2BC12 RAD50 | 7.15e-20 | 158 | 72 | 18 | M26956 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 H2BC12 RAD50 | 2.14e-19 | 68 | 72 | 14 | M27587 |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.18e-18 | 42 | 72 | 12 | M48029 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 STAG2 H2BC12 | 1.71e-18 | 78 | 72 | 14 | M1061 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 PRKN LTF APP H2BC12 | 7.22e-18 | 110 | 72 | 15 | M27958 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 H2BC12 RAD50 | 2.74e-17 | 94 | 72 | 14 | M1080 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 H2BC12 RAD50 | 4.35e-17 | 97 | 72 | 14 | M27590 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.45e-17 | 55 | 72 | 12 | M29526 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 RAD50 | 1.04e-16 | 79 | 72 | 13 | M27191 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.13e-16 | 62 | 72 | 12 | M27700 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 PPP5C BRCA2 H2BC5 H2BC3 H2BC12 RAD50 | 2.24e-16 | 170 | 72 | 16 | M27582 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 BRCA2 H2BC5 H2BC3 H2BC12 RAD50 | 2.99e-16 | 140 | 72 | 15 | M27584 |
| Pathway | REACTOME_DNA_METHYLATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.21e-16 | 64 | 72 | 12 | M27429 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.78e-16 | 66 | 72 | 12 | M27488 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.79e-16 | 67 | 72 | 12 | M27342 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.79e-16 | 67 | 72 | 12 | M39003 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.01e-16 | 68 | 72 | 12 | M27658 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.02e-15 | 70 | 72 | 12 | M48261 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.02e-15 | 70 | 72 | 12 | M48028 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.46e-15 | 72 | 72 | 12 | M29714 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.46e-15 | 72 | 72 | 12 | M27132 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.74e-15 | 73 | 72 | 12 | M27166 |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.45e-15 | 75 | 72 | 12 | M27343 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 APP H2BC12 | 4.38e-15 | 104 | 72 | 13 | M29829 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | H2BC12L H2BC11 TDRKH H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TDRD1 H2BC12 | 7.74e-15 | 139 | 72 | 14 | M715 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.10e-14 | 89 | 72 | 12 | M27943 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.42e-14 | 90 | 72 | 12 | M2158 |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.42e-14 | 90 | 72 | 12 | M27691 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.42e-14 | 90 | 72 | 12 | M29668 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.77e-14 | 91 | 72 | 12 | M27101 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.63e-14 | 93 | 72 | 12 | M27487 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.15e-14 | 94 | 72 | 12 | M27230 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.38e-14 | 96 | 72 | 12 | M27792 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.12e-14 | 97 | 72 | 12 | M48262 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 H2BC12 RAD50 | 1.02e-13 | 167 | 72 | 14 | M19381 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.62e-13 | 105 | 72 | 12 | M27425 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.82e-13 | 106 | 72 | 12 | M27458 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CD80 H2BC5 H2BC3 H2BC12 H2BC18 | 2.03e-13 | 139 | 72 | 13 | M4741 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.05e-13 | 107 | 72 | 12 | M48260 |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.29e-13 | 108 | 72 | 12 | M27426 |
| Pathway | REACTOME_MITOTIC_PROPHASE | H2BC12L H2BC11 VRK2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.69e-13 | 142 | 72 | 13 | M27660 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.87e-13 | 110 | 72 | 12 | M27696 |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.20e-13 | 111 | 72 | 12 | M27187 |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 3.25e-13 | 59 | 72 | 10 | M27763 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.57e-13 | 112 | 72 | 12 | M4052 |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.57e-13 | 112 | 72 | 12 | M48334 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 STAG2 H2BC12 | 5.02e-13 | 149 | 72 | 13 | M27888 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.48e-13 | 116 | 72 | 12 | M29806 |
| Pathway | REACTOME_DNA_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 PPP5C BRCA2 MLH1 H2BC5 H2BC3 H2BC12 RAD50 | 5.88e-13 | 332 | 72 | 17 | M15434 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.47e-13 | 119 | 72 | 12 | M607 |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.01e-12 | 122 | 72 | 12 | M29689 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.35e-12 | 125 | 72 | 12 | M27186 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.80e-12 | 128 | 72 | 12 | M48019 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.98e-12 | 129 | 72 | 12 | M27795 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.44e-12 | 138 | 72 | 12 | M29805 |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C H2BC5 H2BC3 STAG2 H2BC12 | 4.51e-12 | 220 | 72 | 14 | M27794 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.84e-12 | 139 | 72 | 12 | M868 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.25e-12 | 142 | 72 | 12 | M48257 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.25e-12 | 142 | 72 | 12 | M27233 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 6.88e-12 | 79 | 72 | 10 | M27742 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 1.04e-11 | 57 | 72 | 9 | MM15298 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 RAD50 | 1.79e-11 | 197 | 72 | 13 | M27188 |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2BC12L H2BC11 KDM3A H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C H2BC5 H2BC3 STAG2 H2BC12 | 1.88e-11 | 296 | 72 | 15 | M27869 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.39e-11 | 159 | 72 | 12 | M27665 |
| Pathway | REACTOME_HCMV_INFECTION | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.98e-11 | 162 | 72 | 12 | M29804 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 6.94e-11 | 46 | 72 | 8 | MM14935 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 8.33e-11 | 47 | 72 | 8 | MM15296 | |
| Pathway | REACTOME_CELL_CYCLE | H2BC12L H2BC11 VRK2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 BRCA2 MLH1 H2BC5 H2BC3 TEX15 STAG2 H2BC12 FBXW11 RAD50 | 1.49e-10 | 694 | 72 | 20 | M543 |
| Pathway | REACTOME_DNA_REPLICATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.60e-10 | 187 | 72 | 12 | M1017 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 H2BC12 RAD50 | 1.91e-10 | 291 | 72 | 14 | M16647 |
| Pathway | REACTOME_DEUBIQUITINATION | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 PRKN H2BC12 H2BC18 | 2.73e-10 | 299 | 72 | 14 | M27574 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 3.12e-10 | 55 | 72 | 8 | MM14932 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 KDM3A H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 9.92e-10 | 272 | 72 | 13 | M29619 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.10e-09 | 221 | 72 | 12 | M27578 |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.01e-09 | 233 | 72 | 12 | M27099 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.43e-09 | 237 | 72 | 12 | M27786 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 2.86e-09 | 72 | 72 | 8 | MM15381 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC13 H2BC15 H2BC14 H2BC9 BRCA1 PPP5C BRCA2 H2BC5 H2BC3 RAD50 | 3.23e-09 | 146 | 72 | 10 | MM15292 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.71e-09 | 246 | 72 | 12 | M10189 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 3.99e-09 | 75 | 72 | 8 | MM15299 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.32e-09 | 254 | 72 | 12 | M27131 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 6.97e-09 | 116 | 72 | 9 | MM15294 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 9.55e-09 | 31 | 72 | 6 | MM17225 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 9.84e-09 | 54 | 72 | 7 | MM14904 | |
| Pathway | REACTOME_M_PHASE | H2BC12L H2BC11 VRK2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 STAG2 H2BC12 | 1.98e-08 | 417 | 72 | 14 | M27662 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 2.94e-08 | 37 | 72 | 6 | MM14883 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 3.48e-08 | 38 | 72 | 6 | MM15434 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 4.10e-08 | 39 | 72 | 6 | MM14850 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.66e-08 | 323 | 72 | 12 | M27080 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 8.69e-08 | 44 | 72 | 6 | MM15527 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.67e-08 | 330 | 72 | 12 | M7847 |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 9.99e-08 | 45 | 72 | 6 | MM15508 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | H2BC12L H2BC11 VRK2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 STAG2 H2BC12 FBXW11 | 1.17e-07 | 561 | 72 | 15 | M5336 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 1.91e-07 | 50 | 72 | 6 | MM15308 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.48e-07 | 175 | 72 | 9 | MM14941 | |
| Pathway | REACTOME_DNA_REPAIR | H2BC13 H2BC15 H2BC14 H2BC9 BRCA1 PPP5C BRCA2 MLH1 H2BC5 H2BC3 RAD50 | 3.33e-07 | 301 | 72 | 11 | MM15433 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 3.81e-07 | 56 | 72 | 6 | MM17236 | |
| Pubmed | Inhibition of core histones acetylation by carcinogenic nickel(II). | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.99e-28 | 18 | 87 | 12 | 16283522 |
| Pubmed | Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.99e-28 | 18 | 87 | 12 | 12757711 |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.72e-26 | 22 | 87 | 12 | 16713563 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.60e-26 | 23 | 87 | 12 | 16307923 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.27e-24 | 30 | 87 | 12 | 16319397 | |
| Pubmed | Quantitative proteomic analysis of post-translational modifications of human histones. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 5.99e-20 | 17 | 87 | 9 | 16627869 |
| Pubmed | 1.81e-19 | 11 | 87 | 8 | 15197225 | ||
| Pubmed | Histone modifications associated with somatic hypermutation. | 1.81e-19 | 11 | 87 | 8 | 16039583 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 8.77e-19 | 77 | 87 | 12 | 12408966 | |
| Pubmed | Histone H2B as a functionally important plasminogen receptor on macrophages. | 6.99e-18 | 15 | 87 | 8 | 17690254 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.02e-17 | 69 | 87 | 11 | 11689053 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.91e-17 | 73 | 87 | 11 | 14657027 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.91e-17 | 73 | 87 | 11 | 9566873 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.62e-16 | 86 | 87 | 11 | 11080476 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.24e-15 | 67 | 87 | 10 | 25253489 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 ACO2 H2BC5 H2BC3 H2BC12 H2BC18 | 4.34e-15 | 203 | 87 | 13 | 16916647 |
| Pubmed | 1.45e-14 | 55 | 87 | 9 | 9439656 | ||
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 8.65e-14 | 256 | 87 | 13 | 35777956 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 RAD50 | 1.79e-13 | 271 | 87 | 13 | 32433965 |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.37e-13 | 277 | 87 | 13 | 30745168 | |
| Pubmed | Gene-specific characterization of human histone H2B by electron capture dissociation. | 5.22e-13 | 6 | 87 | 5 | 16457587 | |
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 2.20e-12 | 59 | 87 | 8 | 23254330 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 LTF H2BC12 H2BC18 | 4.82e-12 | 438 | 87 | 14 | 21630459 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 ATP7A TXNDC5 ACO2 H2BC5 H2BC3 H2BC18 | 3.23e-11 | 247 | 87 | 11 | 30713523 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 C4orf54 H2BC12 H2BC18 RAD50 | 4.55e-11 | 626 | 87 | 15 | 33644029 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 ACO2 H2BC5 H2BC3 ZNF571 H2BC12 H2BC18 | 1.06e-10 | 451 | 87 | 13 | 36168627 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 1.52e-10 | 212 | 87 | 10 | 23463506 | |
| Pubmed | 1.71e-10 | 14 | 87 | 5 | 10064132 | ||
| Pubmed | Endotoxin-neutralizing antimicrobial proteins of the human placenta. | 1.82e-10 | 5 | 87 | 4 | 11859126 | |
| Pubmed | Biochemical and antibacterial analysis of human wound and blister fluid. | 1.82e-10 | 5 | 87 | 4 | 8620898 | |
| Pubmed | Antimicrobial peptides in the first line defence of human colon mucosa. | 7.28e-10 | 18 | 87 | 5 | 12860195 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.38e-10 | 425 | 87 | 12 | 21081503 | |
| Pubmed | 1.27e-09 | 7 | 87 | 4 | 15019208 | ||
| Pubmed | SLC12A6 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 BRCA1 PYROXD1 ACO2 KIF21A PARP8 H2BC5 H2BC3 LYST STAG2 H2BC12 H2BC18 | 2.30e-09 | 1442 | 87 | 19 | 35575683 | |
| Pubmed | 2.59e-09 | 206 | 87 | 9 | 22174317 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.70e-09 | 477 | 87 | 12 | 31300519 |
| Pubmed | H2BC12L H2BC11 CPNE8 H2BC13 H2BC15 H2BC14 H2BC9 CPNE9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.74e-09 | 844 | 87 | 15 | 25963833 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 29726012 | ||
| Pubmed | Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. | 1.51e-08 | 3 | 87 | 3 | 26824983 | |
| Pubmed | Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. | 1.78e-08 | 12 | 87 | 4 | 16391231 | |
| Pubmed | H2BC12L H2BC11 AAMP H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 TXNDC5 H2BC5 H2BC3 H2BC12 H2BC18 | 3.78e-08 | 878 | 87 | 14 | 37223481 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 TXNDC5 ZSCAN9 H2BC5 PRKN CNR1 H2BC12 | 5.04e-08 | 622 | 87 | 12 | 14574404 | |
| Pubmed | SLC12A6 TDRKH CPNE8 VRK2 ATP7A PDE8A TRPM7 VPS41 TMEM131L LYST FBXW11 | 5.52e-08 | 504 | 87 | 11 | 34432599 | |
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 35205366 | ||
| Pubmed | Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. | 6.04e-08 | 4 | 87 | 3 | 19383374 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 BRCA1 IGLC7 BRCA2 H2BC5 LTF STAG2 H2BC12 RAD50 | 8.40e-08 | 652 | 87 | 12 | 31180492 | |
| Pubmed | 9.46e-08 | 88 | 87 | 6 | 26318153 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 BRCA1 BRCA2 ZNF644 H2BC5 SCAF11 STAG2 KIF20B H2BC12 H2BC18 | 1.05e-07 | 954 | 87 | 14 | 36373674 |
| Pubmed | H2BC11 AAMP H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 TXNDC5 ZNF735 H2BC5 H2BC3 H2BC12 H2BC18 | 1.65e-07 | 1153 | 87 | 15 | 29845934 | |
| Pubmed | 2.28e-07 | 250 | 87 | 8 | 33536335 | ||
| Pubmed | 3.01e-07 | 6 | 87 | 3 | 18481196 | ||
| Pubmed | Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. | 3.01e-07 | 6 | 87 | 3 | 22967069 | |
| Pubmed | 5.25e-07 | 7 | 87 | 3 | 21356067 | ||
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 5.25e-07 | 7 | 87 | 3 | 8858345 | |
| Pubmed | The activity-dependent histone variant H2BE modulates the life span of olfactory neurons. | 5.25e-07 | 7 | 87 | 3 | 23240083 | |
| Pubmed | Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk. | 6.13e-07 | 27 | 87 | 4 | 20610542 | |
| Pubmed | 8.03e-07 | 68 | 87 | 5 | 20496165 | ||
| Pubmed | 8.39e-07 | 8 | 87 | 3 | 9710638 | ||
| Pubmed | ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair. | 8.39e-07 | 8 | 87 | 3 | 22193777 | |
| Pubmed | 1.09e-06 | 31 | 87 | 4 | 20813000 | ||
| Pubmed | TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. | 1.09e-06 | 31 | 87 | 4 | 26095369 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | H2BC11 H2BC13 H2BC15 H2BC14 H2BC4 H2BC17 KIF21A ADAMTS20 H2BC5 H2BC3 H2BC12 RAD50 | 1.34e-06 | 847 | 87 | 12 | 35235311 |
| Pubmed | 1.41e-06 | 33 | 87 | 4 | 19714462 | ||
| Pubmed | Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. | 1.79e-06 | 10 | 87 | 3 | 9736772 | |
| Pubmed | Human histone gene organization: nonregular arrangement within a large cluster. | 1.80e-06 | 35 | 87 | 4 | 9119399 | |
| Pubmed | 2.12e-06 | 149 | 87 | 6 | 25184681 | ||
| Pubmed | 2.46e-06 | 11 | 87 | 3 | 19584272 | ||
| Pubmed | SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. | 2.46e-06 | 11 | 87 | 3 | 11877377 | |
| Pubmed | 3.12e-06 | 40 | 87 | 4 | 20378615 | ||
| Pubmed | 3.27e-06 | 12 | 87 | 3 | 10783165 | ||
| Pubmed | 4.25e-06 | 13 | 87 | 3 | 8858344 | ||
| Pubmed | Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis. | 6.19e-06 | 2 | 87 | 2 | 29480828 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 17924331 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 12833555 | ||
| Pubmed | Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. | 6.19e-06 | 2 | 87 | 2 | 14735173 | |
| Pubmed | Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. | 6.19e-06 | 2 | 87 | 2 | 16032702 | |
| Pubmed | Oral contraceptive use and BRCA penetrance: a case-only study. | 6.19e-06 | 2 | 87 | 2 | 19549808 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 34101484 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 26961146 | ||
| Pubmed | Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study. | 6.19e-06 | 2 | 87 | 2 | 20512419 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 37804357 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 22053997 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 29044548 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 33834176 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 18200524 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 29298688 | ||
| Pubmed | Fertility in women with BRCA mutations: a case-control study. | 6.19e-06 | 2 | 87 | 2 | 19200971 | |
| Pubmed | Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. | 6.19e-06 | 2 | 87 | 2 | 16030099 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 28212807 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 11448436 | ||
| Pubmed | Rapid evolution of BRCA1 and BRCA2 in humans and other primates. | 6.19e-06 | 2 | 87 | 2 | 25011685 | |
| Pubmed | Breast magnetic resonance imaging for screening high-risk women. | 6.19e-06 | 2 | 87 | 2 | 23928241 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 35980168 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 11377596 | ||
| Pubmed | BRCA mutations and risk of prostate cancer in Ashkenazi Jews. | 6.19e-06 | 2 | 87 | 2 | 15131025 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 20033483 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 28862356 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 22425665 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 18752448 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 22425664 | ||
| Interaction | CYLC1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 ACO2 H2BC5 H2BC3 H2BC12 H2BC18 | 5.44e-22 | 20 | 84 | 11 | int:CYLC1 |
| Interaction | CDK5R2 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.34e-21 | 23 | 84 | 11 | int:CDK5R2 |
| Interaction | TNN interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.34e-21 | 23 | 84 | 11 | int:TNN |
| Interaction | DUOX2 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.55e-17 | 30 | 84 | 10 | int:DUOX2 |
| Interaction | HMGN3 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.35e-17 | 64 | 84 | 12 | int:HMGN3 |
| Interaction | FAM47B interactions | 8.19e-17 | 13 | 84 | 8 | int:FAM47B | |
| Interaction | TEX35 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.28e-16 | 57 | 84 | 11 | int:TEX35 |
| Interaction | ZNF474 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 MLH1 H2BC5 H2BC12 H2BC18 | 2.01e-15 | 44 | 84 | 10 | int:ZNF474 |
| Interaction | H2BC14 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 APP H2BC12 H2BC18 | 9.50e-15 | 100 | 84 | 12 | int:H2BC14 |
| Interaction | PDS5B interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 BRCA2 CD80 H2BC5 H2BC3 APP STAG2 H2BC12 H2BC18 | 1.94e-14 | 178 | 84 | 14 | int:PDS5B |
| Interaction | H2AC7 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.19e-14 | 107 | 84 | 12 | int:H2AC7 |
| Interaction | H2AC25 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.86e-14 | 84 | 84 | 11 | int:H2AC25 |
| Interaction | DPPA2 interactions | H2BC11 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.01e-14 | 40 | 84 | 9 | int:DPPA2 |
| Interaction | MCM5 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 PRKN RICTOR APP H2BC12 H2BC18 RAD50 | 1.03e-13 | 420 | 84 | 18 | int:MCM5 |
| Interaction | PCLO interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 PRKN H2BC12 H2BC18 | 2.95e-13 | 70 | 84 | 10 | int:PCLO |
| Interaction | LOC102724334 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.40e-13 | 134 | 84 | 12 | int:LOC102724334 |
| Interaction | HCLS1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.42e-13 | 71 | 84 | 10 | int:HCLS1 |
| Interaction | HMGN4 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.51e-13 | 100 | 84 | 11 | int:HMGN4 |
| Interaction | H2BC18 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 PRKN H2BC12 H2BC18 | 5.36e-13 | 180 | 84 | 13 | int:H2BC18 |
| Interaction | H2BC17 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.77e-13 | 140 | 84 | 12 | int:H2BC17 |
| Interaction | H2BC15 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 8.10e-13 | 144 | 84 | 12 | int:H2BC15 |
| Interaction | H2AC18 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 APP H2BC12 H2BC18 | 1.12e-12 | 148 | 84 | 12 | int:H2AC18 |
| Interaction | H2AC12 interactions | ANKRD31 H2BC11 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.24e-12 | 118 | 84 | 11 | int:H2AC12 |
| Interaction | H2BC13 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 KIF21A H2BC5 H2BC3 H2BC12 H2BC18 | 3.84e-12 | 210 | 84 | 13 | int:H2BC13 |
| Interaction | JPH2 interactions | 7.66e-12 | 25 | 84 | 7 | int:JPH2 | |
| Interaction | HMGN2 interactions | ANKRD31 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.77e-12 | 222 | 84 | 13 | int:HMGN2 |
| Interaction | H2BC1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 APP H2BC12 H2BC18 | 1.01e-11 | 178 | 84 | 12 | int:H2BC1 |
| Interaction | H2AC6 interactions | H2BC11 H2BC13 H2BC15 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.16e-11 | 100 | 84 | 10 | int:H2AC6 |
| Interaction | H2BC26 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.40e-11 | 183 | 84 | 12 | int:H2BC26 |
| Interaction | H2AC1 interactions | 1.48e-11 | 71 | 84 | 9 | int:H2AC1 | |
| Interaction | H2BC11 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.69e-11 | 186 | 84 | 12 | int:H2BC11 |
| Interaction | H2AC13 interactions | H2BC11 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.46e-11 | 75 | 84 | 9 | int:H2AC13 |
| Interaction | H2AC11 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 FAM217B H2BC5 H2BC3 PRKN H2BC12 H2BC18 | 3.13e-11 | 248 | 84 | 13 | int:H2AC11 |
| Interaction | H2AX interactions | H2BC11 ZCCHC9 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 BRCA2 MLH1 H2BC5 H2BC3 ZMAT1 H2BC12 H2BC18 RAD50 | 3.31e-11 | 593 | 84 | 18 | int:H2AX |
| Interaction | SFMBT2 interactions | 5.24e-11 | 32 | 84 | 7 | int:SFMBT2 | |
| Interaction | H2BC21 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 ZNF695 H2BC21 BRCA1 ZNF644 NABP2 H2BC5 H2BC3 PRKN SCAF11 H2BC12 H2BC18 RAD50 | 5.33e-11 | 696 | 84 | 19 | int:H2BC21 |
| Interaction | RPS27A interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C ACO2 MLH1 H2BC5 H2BC3 PRKN APP H2BC12 H2BC18 | 6.38e-11 | 536 | 84 | 17 | int:RPS27A |
| Interaction | MAP1B interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C H2BC5 H2BC3 PRKN RICTOR H2BC12 H2BC18 FBXW11 | 6.96e-11 | 539 | 84 | 17 | int:MAP1B |
| Interaction | H2BC3 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 APP STAG2 H2BC12 H2BC18 | 1.18e-10 | 406 | 84 | 15 | int:H2BC3 |
| Interaction | H2AJ interactions | H2BC11 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 KIF20B H2BC12 H2BC18 | 1.28e-10 | 127 | 84 | 10 | int:H2AJ |
| Interaction | HMGA1 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 BRCA2 ZNF644 H2BC5 H2BC3 SCAF11 APP H2BC12 H2BC18 | 1.83e-10 | 419 | 84 | 15 | int:HMGA1 |
| Interaction | H2AC14 interactions | H2BC11 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.45e-10 | 144 | 84 | 10 | int:H2AC14 |
| Interaction | PSMD14 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 PRKN APP H2BC12 H2BC18 | 4.73e-10 | 527 | 84 | 16 | int:PSMD14 |
| Interaction | H2AC20 interactions | H2BC11 MELTF H2BC15 H2BC9 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 PRKN APP H2BC12 H2BC18 | 7.28e-10 | 320 | 84 | 13 | int:H2AC20 |
| Interaction | H2BC4 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 STAG2 H2BC12 H2BC18 | 7.83e-10 | 259 | 84 | 12 | int:H2BC4 |
| Interaction | H2BC12 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 STAG2 H2BC12 H2BC18 | 7.86e-10 | 322 | 84 | 13 | int:H2BC12 |
| Interaction | PDCD4 interactions | H2BC11 AAMP H2BC14 H2BC9 H2BC4 H2BC21 H2BC5 PRKN H2BC12 FBXW11 | 3.16e-09 | 176 | 84 | 10 | int:PDCD4 |
| Interaction | UBA52 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 PRKN RICTOR H2BC12 H2BC18 | 3.29e-09 | 437 | 84 | 14 | int:UBA52 |
| Interaction | H2BC9 interactions | H2BC11 NRG1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TEX15 H2BC12 H2BC18 | 4.27e-09 | 446 | 84 | 14 | int:H2BC9 |
| Interaction | ELK4 interactions | 4.54e-09 | 92 | 84 | 8 | int:ELK4 | |
| Interaction | UBB interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 PRKN APP H2BC12 H2BC18 | 7.66e-09 | 467 | 84 | 14 | int:UBB |
| Interaction | H2BC5 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.24e-08 | 331 | 84 | 12 | int:H2BC5 |
| Interaction | ARHGAP24 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 ACO2 H2BC5 H2BC3 ZNF571 APP H2BC12 H2BC18 | 1.27e-08 | 486 | 84 | 14 | int:ARHGAP24 |
| Interaction | ADARB1 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 APP H2BC12 H2BC18 RAD50 | 1.37e-08 | 489 | 84 | 14 | int:ADARB1 |
| Interaction | TMEM196 interactions | 1.94e-08 | 8 | 84 | 4 | int:TMEM196 | |
| Interaction | H2AC4 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 SCAF11 H2BC12 H2BC18 | 2.10e-08 | 506 | 84 | 14 | int:H2AC4 |
| Interaction | EIF1AX interactions | 2.33e-08 | 113 | 84 | 8 | int:EIF1AX | |
| Interaction | DOK2 interactions | 2.86e-08 | 116 | 84 | 8 | int:DOK2 | |
| Interaction | H2AZ2 interactions | 3.38e-08 | 168 | 84 | 9 | int:H2AZ2 | |
| Interaction | TMA7 interactions | 3.59e-08 | 46 | 84 | 6 | int:TMA7 | |
| Interaction | TTN interactions | H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 BRCA1 ACO2 H2BC5 PRKN H2BC12 H2BC18 | 4.53e-08 | 299 | 84 | 11 | int:TTN |
| Interaction | IPO9 interactions | H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 RICTOR APP H2BC12 H2BC18 | 5.19e-08 | 236 | 84 | 10 | int:IPO9 |
| Interaction | IGSF8 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 5.84e-08 | 239 | 84 | 10 | int:IGSF8 |
| Interaction | H3-3A interactions | H2BC11 KDM3A H2BC13 H2BC9 H2BC4 H2BC21 BRCA1 ZNF644 MLH1 H2BC5 PRKN SCAF11 STAG2 KIF20B H2BC12 RAD50 | 6.82e-08 | 749 | 84 | 16 | int:H3-3A |
| Interaction | NBN interactions | 7.07e-08 | 183 | 84 | 9 | int:NBN | |
| Interaction | ICAM1 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 9.59e-08 | 252 | 84 | 10 | int:ICAM1 |
| Interaction | EIF4B interactions | H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 MTM1 H2BC5 PRKN H2BC12 H2BC18 FBXW11 RAD50 | 1.04e-07 | 402 | 84 | 12 | int:EIF4B |
| Interaction | PRKCB interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC21 H2BC5 H2BC3 PRKN RICTOR H2BC12 | 1.07e-07 | 255 | 84 | 10 | int:PRKCB |
| Interaction | ADAMTS12 interactions | 1.08e-07 | 55 | 84 | 6 | int:ADAMTS12 | |
| Interaction | MAPK7 interactions | 1.46e-07 | 143 | 84 | 8 | int:MAPK7 | |
| Interaction | BTF3 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 APP C4orf54 H2BC12 H2BC18 RAD50 | 1.65e-07 | 799 | 84 | 16 | int:BTF3 |
| Interaction | CEP350 interactions | 2.00e-07 | 149 | 84 | 8 | int:CEP350 | |
| Interaction | TOMM70 interactions | 2.46e-07 | 153 | 84 | 8 | int:TOMM70 | |
| Interaction | LMNTD1 interactions | 2.79e-07 | 4 | 84 | 3 | int:LMNTD1 | |
| Interaction | MYH10 interactions | H2BC13 H2BC14 H2BC9 H2BC4 BRCA1 PPP5C H2BC5 PRKN RICTOR H2BC12 RAD50 | 2.86e-07 | 359 | 84 | 11 | int:MYH10 |
| Interaction | H3-4 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 TRPM7 KIF21A H2BC5 H2BC12 RAD50 | 3.34e-07 | 448 | 84 | 12 | int:H3-4 |
| Interaction | MCM2 interactions | H2BC12L H2BC11 CPNE8 H2BC13 H2BC15 H2BC14 H2BC9 CPNE9 H2BC4 H2BC17 H2BC21 BRCA1 H2BC5 H2BC3 PRKN APP H2BC12 H2BC18 | 3.85e-07 | 1081 | 84 | 18 | int:MCM2 |
| Interaction | H2AZ1 interactions | H2BC11 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 ZNF644 H2BC5 H2BC3 H2BC12 H2BC18 | 3.96e-07 | 371 | 84 | 11 | int:H2AZ1 |
| Interaction | MAP7D2 interactions | 4.63e-07 | 70 | 84 | 6 | int:MAP7D2 | |
| Interaction | CD81 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 5.26e-07 | 303 | 84 | 10 | int:CD81 |
| Interaction | RIOK1 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 APP H2BC12 H2BC18 | 5.49e-07 | 562 | 84 | 13 | int:RIOK1 |
| Interaction | H2AC21 interactions | 5.68e-07 | 234 | 84 | 9 | int:H2AC21 | |
| Interaction | H1-2 interactions | SLC12A6 ZCCHC9 H2BC9 H2BC4 H2BC21 PPP5C H2BC5 H2BC3 PRKN APP KIF20B H2BC12 H2BC18 RAD50 | 6.06e-07 | 666 | 84 | 14 | int:H1-2 |
| Interaction | KMT2A interactions | 7.28e-07 | 314 | 84 | 10 | int:KMT2A | |
| Interaction | PINK1 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 PRKN RICTOR H2BC12 H2BC18 | 7.63e-07 | 679 | 84 | 14 | int:PINK1 |
| Interaction | H3C1 interactions | H2BC11 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 ACO2 ZNF644 H2BC5 H2BC3 STAG2 KIF20B H2BC12 H2BC18 RAD50 | 8.19e-07 | 901 | 84 | 16 | int:H3C1 |
| Interaction | CKAP5 interactions | H2BC11 H2BC13 H2BC9 H2BC4 BRCA1 H2BC5 PRKN RICTOR STAG2 H2BC12 | 9.15e-07 | 322 | 84 | 10 | int:CKAP5 |
| Interaction | SPAG17 interactions | 1.29e-06 | 20 | 84 | 4 | int:SPAG17 | |
| Interaction | USF3 interactions | 1.29e-06 | 20 | 84 | 4 | int:USF3 | |
| Interaction | EPRS1 interactions | H2BC13 H2BC9 H2BC4 H2BC21 BRCA1 ACO2 H2BC5 H2BC3 PRKN RICTOR H2BC12 FBXW11 | 1.39e-06 | 513 | 84 | 12 | int:EPRS1 |
| Interaction | TOP2A interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 BRCA1 BRCA2 H2BC5 PRKN H2BC12 H2BC18 | 1.60e-06 | 520 | 84 | 12 | int:TOP2A |
| Interaction | INIP interactions | 1.66e-06 | 48 | 84 | 5 | int:INIP | |
| Interaction | H3C15 interactions | 2.42e-06 | 207 | 84 | 8 | int:H3C15 | |
| Interaction | ABCF2 interactions | 2.60e-06 | 209 | 84 | 8 | int:ABCF2 | |
| Interaction | OSBPL9 interactions | 3.01e-06 | 96 | 84 | 6 | int:OSBPL9 | |
| Interaction | SMC5 interactions | H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 BRCA1 BRCA2 ZNF644 H2BC5 PRKN SCAF11 STAG2 KIF20B H2BC12 H2BC18 RAD50 | 3.18e-06 | 1000 | 84 | 16 | int:SMC5 |
| Interaction | H3C14 interactions | 4.00e-06 | 156 | 84 | 7 | int:H3C14 | |
| Interaction | C11orf58 interactions | 4.04e-06 | 101 | 84 | 6 | int:C11orf58 | |
| Interaction | NAA15 interactions | 4.35e-06 | 158 | 84 | 7 | int:NAA15 | |
| Interaction | PRMT8 interactions | 4.79e-06 | 104 | 84 | 6 | int:PRMT8 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 ZSCAN9 H2BC5 H2BC3 H2BC12 | 1.63e-10 | 378 | 87 | 11 | chr6p22 |
| Cytoband | 6p22.1 | 3.24e-07 | 142 | 87 | 6 | 6p22.1 | |
| Cytoband | 12q12 | 2.02e-06 | 47 | 87 | 4 | 12q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q12 | 6.58e-06 | 63 | 87 | 4 | chr12q12 | |
| Cytoband | 6p21.3 | 1.34e-03 | 250 | 87 | 4 | 6p21.3 | |
| Cytoband | 8p12 | 3.63e-03 | 47 | 87 | 2 | 8p12 | |
| GeneFamily | Histones | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.65e-16 | 116 | 68 | 13 | 864 |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 2.24e-05 | 15 | 68 | 3 | 903 | |
| GeneFamily | Transferrins | 4.17e-05 | 3 | 68 | 2 | 908 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.38e-04 | 5 | 68 | 2 | 1336 | |
| GeneFamily | Copines | 4.93e-04 | 9 | 68 | 2 | 829 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 6.15e-04 | 10 | 68 | 2 | 1178 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 2.53e-03 | 20 | 68 | 2 | 548 | |
| GeneFamily | Phosphoinositide phosphatases | 6.43e-03 | 32 | 68 | 2 | 1079 | |
| GeneFamily | Tudor domain containing | 8.53e-03 | 37 | 68 | 2 | 780 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | H2BC11 H2BC13 H2BC15 H2BC14 H2BC4 H2BC21 ZNF423 HECTD4 H2BC5 H2BC12 | 1.14e-09 | 200 | 86 | 10 | M9952 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | H2BC12L H2BC11 KDM3A ZCCHC9 AHRR H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 ZNF695 H2BC21 H2BC5 H2BC3 H2BC12 | 2.78e-08 | 768 | 86 | 15 | M6444 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 BRCA1 PPP5C BRCA2 NABP2 MLH1 H2BC3 KIF20B RAD54L H2BC18 | 5.71e-08 | 694 | 86 | 14 | M45767 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 8.23e-08 | 111 | 86 | 7 | MM705 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | H2BC11 H2BC15 H2BC9 H2BC4 BRCA1 BRCA2 MLH1 H2BC3 KIF20B RAD54L H2BC18 | 2.60e-07 | 450 | 86 | 11 | M45747 |
| Coexpression | DANG_BOUND_BY_MYC | H2BC12L H2BC11 MELTF H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 ASAH1 ACO2 ZSCAN9 APP KIF20B RAD54L AZIN1 | 3.12e-07 | 1061 | 86 | 16 | M15774 |
| Coexpression | HASLINGER_B_CLL_WITH_6Q21_DELETION | 7.55e-07 | 22 | 86 | 4 | M7362 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 7.65e-07 | 96 | 86 | 6 | M1683 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | H2BC11 H2BC13 H2BC9 H2BC4 H2BC17 BRCA2 NABP2 H2BC5 H2BC3 H2BC12 RAD54L H2BC18 | 3.69e-06 | 714 | 86 | 12 | M1744 |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 4.23e-06 | 199 | 86 | 7 | M9420 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN | 4.23e-06 | 199 | 86 | 7 | M9954 | |
| Coexpression | BENPORATH_MYC_MAX_TARGETS | H2BC12L H2BC11 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 ASAH1 KIF20B RAD54L AZIN1 RAD50 | 8.45e-06 | 775 | 86 | 12 | M17753 |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN | 8.67e-06 | 222 | 86 | 7 | M16955 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 BRCA1 BRCA2 MLH1 H2BC3 KIF20B RAD54L H2BC18 | 1.14e-05 | 939 | 86 | 13 | M45768 |
| Coexpression | PARK_APL_PATHOGENESIS_DN | 1.88e-05 | 48 | 86 | 4 | M2541 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 2.75e-05 | 478 | 86 | 9 | M45785 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 4.90e-05 | 198 | 86 | 6 | MM17083 | |
| Coexpression | GSE22886_CTRL_VS_LPS_24H_DC_DN | 5.18e-05 | 200 | 86 | 6 | M4520 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 5.18e-05 | 200 | 86 | 6 | M7168 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 5.34e-05 | 402 | 86 | 8 | MM454 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ZCCHC9 BRCA1 PYROXD1 ASAH1 ZNF644 VPS41 SCAF11 STAG2 KIF20B RAD50 | 5.77e-05 | 656 | 86 | 10 | M18979 |
| Coexpression | FISCHER_DREAM_TARGETS | H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 ZNF695 H2BC21 BRCA1 BRCA2 KIF20B RAD54L AZIN1 | 7.51e-05 | 969 | 86 | 12 | M149 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM3A NRG1 PDE8A BRCA1 BRCA2 TMEM131L APP STAG2 KIF20B FBXW11 AZIN1 | 1.11e-04 | 856 | 86 | 11 | M4500 |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN | 1.38e-04 | 590 | 86 | 9 | M16066 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | H2BC11 VRK2 H2BC15 H2BC9 H2BC4 BRCA1 PPP5C BRCA2 PYROXD1 NABP2 MLH1 KIF20B RAD54L H2BC18 | 2.09e-04 | 1423 | 86 | 14 | M45722 |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 2.33e-04 | 168 | 86 | 5 | M18811 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL | 2.73e-04 | 384 | 86 | 7 | M45735 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | 2.48e-09 | 32 | 83 | 6 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | 1.06e-08 | 70 | 83 | 7 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K1 | 3.14e-08 | 125 | 83 | 8 | facebase_RNAseq_e9.5_MandArch_2500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | 4.11e-08 | 50 | 83 | 6 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 2.48e-07 | 110 | 83 | 7 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | 3.77e-07 | 72 | 83 | 6 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K2 | 2.20e-06 | 54 | 83 | 5 | facebase_RNAseq_e9.5_FaceMes_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | 2.74e-06 | 157 | 83 | 7 | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | IL12A H2BC13 H2BC14 H2BC9 BRCA1 BRCA2 H2BC3 LTF KIF20B RAD54L | 2.75e-06 | 388 | 83 | 10 | GSM538352_500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | 3.15e-06 | 58 | 83 | 5 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | 3.37e-06 | 162 | 83 | 7 | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | IL12A H2BC13 H2BC14 BRCA1 BRCA2 PARP8 H2BC3 LTF KIF20B RAD54L | 3.52e-06 | 399 | 83 | 10 | GSM538345_500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | IL12A H2BC13 H2BC14 H2BC9 BRCA1 BRCA2 H2BC3 LTF KIF20B RAD54L | 4.38e-06 | 409 | 83 | 10 | GSM399452_500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | IL12A H2BC13 H2BC14 H2BC9 H2BC4 BRCA1 BRCA2 H2BC3 KIF20B RAD54L | 5.30e-06 | 418 | 83 | 10 | GSM538350_500 |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R-, Bone marrow, avg-2 | IL12A H2BC13 H2BC14 BRCA1 BRCA2 PARP8 H2BC3 LTF KIF20B RAD54L | 5.77e-06 | 422 | 83 | 10 | GSM791124_500 |
| CoexpressionAtlas | B cells, B.Pl.AA4+220-.BM, CD138+ AA4.1+ CD43- CD45R-, Bone marrow, avg-3 | 7.05e-06 | 339 | 83 | 9 | GSM777027_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | 1.61e-05 | 376 | 83 | 9 | GSM538418_500 | |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | SLC12A6 IL12A H2BC13 H2BC14 BRCA1 TMEM131L H2BC3 KIF20B RAD54L | 2.38e-05 | 395 | 83 | 9 | GSM538340_500 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | 2.38e-05 | 43 | 83 | 4 | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 2.52e-05 | 398 | 83 | 9 | GSM399397_500 | |
| CoexpressionAtlas | Stem Cells, SC.MPP34F.BM, Lineage- cKit+ Sca-1+ flk2+ CD34+, Bone marrow, avg-2 | 2.68e-05 | 401 | 83 | 9 | GSM791110_500 | |
| CoexpressionAtlas | Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3 | 2.73e-05 | 402 | 83 | 9 | GSM791105_500 | |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 3.18e-05 | 410 | 83 | 9 | GSM791122_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 3.77e-05 | 419 | 83 | 9 | GSM538348_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | 5.09e-05 | 52 | 83 | 4 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | TDRKH AAMP BRCA1 BRCA2 KIF21A RICTOR TEX15 NABP1 TDRD1 KIF20B RAD54L RAD50 | 7.04e-05 | 810 | 83 | 12 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | 1.36e-04 | 387 | 83 | 8 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 1.62e-04 | 397 | 83 | 8 | GSM791143_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | 1.70e-04 | 400 | 83 | 8 | GSM538358_500 | |
| CoexpressionAtlas | Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3 | 1.73e-04 | 401 | 83 | 8 | GSM791114_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 2.01e-04 | 410 | 83 | 8 | GSM538387_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | H2BC11 H2BC13 H2BC15 H2BC14 H2BC17 BRCA1 BRCA2 KIF21A H2BC5 H2BC3 PRKN NABP1 H2BC12 H2BC18 | 2.17e-04 | 1202 | 83 | 14 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 2.26e-04 | 417 | 83 | 8 | GSM399403_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ZCCHC9 BRCA1 BRCA2 TRPM7 ZNF423 ZNF644 KIF21A TMEM131L TDRD1 KIF20B CNR1 H2BC18 RAD50 | 2.27e-04 | 1060 | 83 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 2.45e-04 | 422 | 83 | 8 | GSM538357_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 2.45e-04 | 422 | 83 | 8 | GSM538355_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 2.74e-04 | 80 | 83 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ZCCHC9 PDE8A BRCA1 BRCA2 TRPM7 ZNF644 MLH1 TMEM131L SCAF11 TDRD1 KIF20B PTGR3 H2BC18 RAD50 | 3.01e-04 | 1241 | 83 | 14 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | TDRKH PDE8A BRCA1 PPP5C BRCA2 TEX15 NABP1 TDRD1 LYST RAD54L RAD50 | 3.40e-04 | 820 | 83 | 11 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ZCCHC9 BRCA1 BRCA2 TRPM7 PYROXD1 ZNF644 KIF21A MLH1 TMEM131L SCAF11 KIF20B RAD54L H2BC18 RAD50 | 3.43e-04 | 1257 | 83 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.88e-04 | 166 | 83 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ZCCHC9 PDE8A BRCA1 BRCA2 TRPM7 ZNF644 MLH1 TMEM131L SCAF11 TDRD1 KIF20B CNR1 PTGR3 H2BC18 RAD50 | 5.14e-04 | 1468 | 83 | 15 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.40e-04 | 268 | 83 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_500 | 6.76e-04 | 376 | 83 | 7 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 6.79e-04 | 44 | 83 | 3 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k4_500 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | 7.19e-04 | 380 | 83 | 7 | GSM538207_500 | |
| CoexpressionAtlas | B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3 | 7.53e-04 | 383 | 83 | 7 | GSM399448_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.25e-04 | 107 | 83 | 4 | gudmap_developingGonad_e16.5_ovary_1000_k4 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.BM, B220neg CD3neg CD115+ Ly-6C+, Bone marrow, avg-3 | 8.50e-04 | 391 | 83 | 7 | GSM854329_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#3 | 8.54e-04 | 108 | 83 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K3 | |
| CoexpressionAtlas | B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2 | 8.88e-04 | 394 | 83 | 7 | GSM777030_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | SLC12A6 TDRKH ATP7A TRPM7 MTM1 SCAF11 TEX15 NABP1 ZMAT1 CNR1 | 8.94e-04 | 778 | 83 | 10 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | 9.15e-04 | 396 | 83 | 7 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 9.42e-04 | 192 | 83 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 9.46e-04 | 111 | 83 | 4 | ratio_SC_vs_MESO_1000_K2 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | 9.84e-04 | 401 | 83 | 7 | GSM399450_500 | |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | 9.84e-04 | 401 | 83 | 7 | GSM791108_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | 9.98e-04 | 402 | 83 | 7 | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 9.98e-04 | 402 | 83 | 7 | GSM605898_500 | |
| CoexpressionAtlas | bone marrow | 9.99e-04 | 292 | 83 | 6 | bone marrow | |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Bone marrow, avg-2 | 1.03e-03 | 404 | 83 | 7 | GSM791129_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | 1.04e-03 | 405 | 83 | 7 | GSM538343_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.11e-03 | 298 | 83 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.15e-03 | 300 | 83 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K1 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | 1.18e-03 | 414 | 83 | 7 | GSM476660_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, AA4.1+ CD117+ IL7R+ CD45R+ CD24- CD19- IgM-, Bone marrow, avg-1 | 1.23e-03 | 304 | 83 | 6 | GSM538354_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3 | 1.25e-03 | 418 | 83 | 7 | GSM605836_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 1.27e-03 | 419 | 83 | 7 | GSM476664_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | 1.29e-03 | 420 | 83 | 7 | GSM791141_500 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | 1.32e-03 | 422 | 83 | 7 | GSM399442_500 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 1.34e-03 | 423 | 83 | 7 | GSM791126_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 1.37e-03 | 56 | 83 | 3 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Lu, CD11chi CD11b- CD103- MHCII- SiglecF+, Lung, avg-3 | 1.38e-03 | 425 | 83 | 7 | GSM538282_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 1.38e-03 | 425 | 83 | 7 | GSM538255_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.38e-03 | 123 | 83 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ZCCHC9 BRCA1 BRCA2 TRPM7 PYROXD1 ZNF644 KIF21A MLH1 TMEM131L SCAF11 KIF20B RAD54L H2BC18 RAD50 | 1.48e-03 | 1459 | 83 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | Stem Cells, SC.CMP.BM, Lineage- Kit+ Sca1- CD34+ FcgRlow, Bone marrow, avg-2 | 1.52e-03 | 317 | 83 | 6 | GSM791117_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | TDRKH CPNE9 H2BC21 PDE8A BRCA1 BRCA2 KIF21A MTMR1 SCAF11 ZMAT1 KIF20B | 1.55e-03 | 986 | 83 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#1 | 1.79e-03 | 132 | 83 | 4 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.05e-03 | 137 | 83 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K4 | |
| CoexpressionAtlas | B cells, B.Pl.AA4+220+.BM, CD138+ AA4.1+ CD43- CD45R+, Bone marrow, avg-3 | 2.07e-03 | 337 | 83 | 6 | GSM777024_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, AA4.1+ CD117+ IL7R+ CD45R- CD24- CD19- IgM-, Bone marrow, avg-1 | 2.10e-03 | 338 | 83 | 6 | GSM538347_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.17e-03 | 232 | 83 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | H2BC13 H2BC14 H2BC9 H2BC17 BRCA1 BRCA2 H2BC5 H2BC3 KIF20B RAD54L | 5.84e-12 | 196 | 87 | 10 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.57e-10 | 193 | 87 | 9 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.73e-09 | 200 | 87 | 8 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.51e-08 | 180 | 87 | 7 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.51e-08 | 180 | 87 | 7 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 1.12e-07 | 195 | 87 | 7 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 195 | 87 | 7 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.21e-07 | 197 | 87 | 7 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-07 | 197 | 87 | 7 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-07 | 197 | 87 | 7 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-07 | 197 | 87 | 7 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.21e-07 | 197 | 87 | 7 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-07 | 198 | 87 | 7 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-07 | 198 | 87 | 7 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.34e-07 | 200 | 87 | 7 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.81e-07 | 158 | 87 | 6 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | Control-Lymphocyte-B-Plasmablast|Control / Disease, Lineage and Cell Type | 7.88e-07 | 162 | 87 | 6 | 67b32c40cc180c5ebbfd901a417b5be469500110 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 174 | 87 | 6 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 174 | 87 | 6 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 179 | 87 | 6 | b88791dd4e73bb8410ca090938a1a45b0bc16e69 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 179 | 87 | 6 | c063028b82c68d929aef2421daade9dc189a6963 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-06 | 181 | 87 | 6 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-06 | 185 | 87 | 6 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-06 | 185 | 87 | 6 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.71e-06 | 185 | 87 | 6 | 698ff44fd2d9b3ad5cea45f4cff9bfc64c559b62 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-06 | 186 | 87 | 6 | 981116561986f94e9cc3ee64fb37dab9a31d427a | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|World / disease group, cell group and cell class (v2) | 1.99e-06 | 190 | 87 | 6 | 7aaf82f0c235363afb95cf1fa51c2a5b070b1af8 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-06 | 191 | 87 | 6 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-06 | 191 | 87 | 6 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-06 | 195 | 87 | 6 | 027075e9c62b5754a014a9d1393e1b0f5ae42e41 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 2.31e-06 | 195 | 87 | 6 | 1390728b9a514db534e8bc6dcf72cf51a1065780 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid-Megakaryocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-06 | 195 | 87 | 6 | 1bcc0c8b1281396b1433ce5a2ec8681de47ce9ad | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-06 | 197 | 87 | 6 | 0d38d126b1e653398426255e95449f1150eac1b0 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Plasma_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.46e-06 | 197 | 87 | 6 | 7ffb373d5b72c67e4816f14ea9a7a2024dc7a93a | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.46e-06 | 197 | 87 | 6 | 2e76e9ebd8702bfeefd396cbf5114eee0f24c19b | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.46e-06 | 197 | 87 | 6 | 207fce47e547fafbaf64a22efe3488e74bf19bed | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-06 | 197 | 87 | 6 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-06 | 197 | 87 | 6 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-06 | 197 | 87 | 6 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.53e-06 | 198 | 87 | 6 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.53e-06 | 198 | 87 | 6 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.53e-06 | 198 | 87 | 6 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.68e-06 | 200 | 87 | 6 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | e1b3fc516887510b18cf688ada0e00b5f5eff684 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-05 | 147 | 87 | 5 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-05 | 154 | 87 | 5 | f78b01c19afcbab6319f61e4d6023ecb3d510d24 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-05 | 157 | 87 | 5 | f896997490bb2eec598c6581f161220e70f9a991 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.42e-05 | 157 | 87 | 5 | 14a8516346a89a89f1119b744625bd9844a74a03 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Platelet|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.56e-05 | 160 | 87 | 5 | 768f3cefc3ad4cda229e598cce8bde574cf64bb2 | |
| ToppCell | PBMC-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 1.56e-05 | 160 | 87 | 5 | 4dac64e58d9366c399f3d830848ccb720d400be7 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-05 | 165 | 87 | 5 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 2.15e-05 | 171 | 87 | 5 | 976361f67dd725870e0513ae7a92f2dcaee17148 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 171 | 87 | 5 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-05 | 171 | 87 | 5 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 2.21e-05 | 172 | 87 | 5 | 8156fb6de66a4c92ade703b71c2e9187291e50ef | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-05 | 172 | 87 | 5 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 173 | 87 | 5 | c399786aa25bdbe3394988db6955842b5b7e6b41 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 173 | 87 | 5 | 31784679190fbd95fc23d7c66008eb21b8c7cc5d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 173 | 87 | 5 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.53e-05 | 177 | 87 | 5 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.53e-05 | 177 | 87 | 5 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Platelet|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 181 | 87 | 5 | 724efbc200e8388829bc7d81830c2689a95fa838 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 182 | 87 | 5 | 0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 182 | 87 | 5 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 2.90e-05 | 182 | 87 | 5 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | wk_15-18-Epithelial-PNS-SST+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.90e-05 | 182 | 87 | 5 | a7e77aaaddabf78c7784f72b3431703fc5ee4a8c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 183 | 87 | 5 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 184 | 87 | 5 | abb61e744a9031e0c91eb560a8f486a0ca5a01cc | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-05 | 185 | 87 | 5 | ff598af88c7f9d7224cc4ed96b1c3463ef76b550 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-05 | 185 | 87 | 5 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-05 | 185 | 87 | 5 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.13e-05 | 185 | 87 | 5 | 709236097cbfc254796fcc69b5f5178b73dad9bd | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.13e-05 | 185 | 87 | 5 | af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_large-bowel / Manually curated celltypes from each tissue | 3.13e-05 | 185 | 87 | 5 | 2cad994207c4afc9d70f4c2d243ffbbcdbba693e | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma|GI_large-bowel / Manually curated celltypes from each tissue | 3.13e-05 | 185 | 87 | 5 | 989583c487d8c121e3731faf68f863ba43a582e6 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 3.13e-05 | 185 | 87 | 5 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 3.21e-05 | 186 | 87 | 5 | 17eec1efad1f5e9ced1eb6bc9eb5dd7ded789c61 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.38e-05 | 188 | 87 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.47e-05 | 189 | 87 | 5 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 189 | 87 | 5 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Mast_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 189 | 87 | 5 | 7bc6e152fb4fe5cd6db9407929c15843a5d8f8c4 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 189 | 87 | 5 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-05 | 189 | 87 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | B_cells-Plasmablasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.47e-05 | 189 | 87 | 5 | 87cb7b6ba9fd57100d68e6eaeecd1ac6ab22d1c6 | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 3.65e-05 | 191 | 87 | 5 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 3.83e-05 | 193 | 87 | 5 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.93e-05 | 194 | 87 | 5 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 3.93e-05 | 194 | 87 | 5 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | Biopsy_Control_(H.)-Immune-pDCs|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.02e-05 | 195 | 87 | 5 | 47d139215f0b51f5ea9b5fb09b1100e320e3f1e2 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 195 | 87 | 5 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 195 | 87 | 5 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.02e-05 | 195 | 87 | 5 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 195 | 87 | 5 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.02e-05 | 195 | 87 | 5 | df009b18898c10686f75cf72b4ec0eff18f5bb50 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.22e-05 | 197 | 87 | 5 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.22e-05 | 197 | 87 | 5 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 4.22e-05 | 197 | 87 | 5 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | MS-IIF-Lymphocyte-B-Plasmablast|IIF / Disease, condition lineage and cell class | 4.22e-05 | 197 | 87 | 5 | 1b5ac53297cc557e08b9e8e511c2385a38f56bd6 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.33e-05 | 198 | 87 | 5 | 5c14b152912429f099dfcb6bcb1aec80314a3284 | |
| ToppCell | distal-3-Hematologic-Proliferating_NK/T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.33e-05 | 198 | 87 | 5 | aa23119d73554733981df474648e59918d04edfc | |
| Computational | Genes in the cancer module 127. | 9.77e-08 | 26 | 49 | 5 | MODULE_127 | |
| Computational | Genes in the cancer module 89. | 3.69e-07 | 14 | 49 | 4 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 6.66e-07 | 16 | 49 | 4 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 8.68e-07 | 17 | 49 | 4 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 1.11e-06 | 18 | 49 | 4 | MODULE_552 | |
| Computational | Genes in the cancer module 534. | 1.11e-06 | 18 | 49 | 4 | MODULE_534 | |
| Computational | Genes in the cancer module 222. | 2.62e-06 | 22 | 49 | 4 | MODULE_222 | |
| Computational | Genes in the cancer module 168. | 2.62e-06 | 22 | 49 | 4 | MODULE_168 | |
| Computational | Genes in the cancer module 189. | 3.17e-06 | 23 | 49 | 4 | MODULE_189 | |
| Computational | Chromatin. | 7.20e-06 | 28 | 49 | 4 | MODULE_421 | |
| Computational | Genes in the cancer module 138. | 6.43e-04 | 87 | 49 | 4 | MODULE_138 | |
| Computational | TFs and nuclear. | 6.82e-04 | 237 | 49 | 6 | MODULE_252 | |
| Drug | Methylmethacrylate | 1.51e-12 | 39 | 85 | 8 | ctd:D020366 | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.20e-08 | 178 | 85 | 9 | 6220_UP | |
| Drug | Berberine | 6.55e-08 | 202 | 85 | 9 | ctd:D001599 | |
| Drug | manganese | IL12A H2BC17 H2BC21 PDE8A BRCA1 PPP5C TRPM7 CD80 ACO2 SCAF11 LTF APP H2BC12 RAD50 | 1.28e-06 | 791 | 85 | 14 | CID000023930 |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 6.48e-06 | 187 | 85 | 7 | 6995_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; HL60; HT_HG-U133A | 8.52e-06 | 195 | 85 | 7 | 2736_UP | |
| Drug | olaparib | 1.08e-05 | 12 | 85 | 3 | ctd:C531550 | |
| Drug | dibenzofuran | 1.21e-05 | 38 | 85 | 4 | ctd:C023614 | |
| Drug | OTX015 | 2.72e-05 | 16 | 85 | 3 | ctd:C000605331 | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.03e-05 | 160 | 85 | 6 | 5364_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 3.73e-05 | 166 | 85 | 6 | 3290_UP | |
| Drug | Clorgyline | 3.99e-05 | 168 | 85 | 6 | ctd:D003010 | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 3.99e-05 | 168 | 85 | 6 | 2801_UP | |
| Drug | EDP-420 | 4.12e-05 | 3 | 85 | 2 | CID009579292 | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 4.40e-05 | 171 | 85 | 6 | 2723_UP | |
| Drug | sebacate | 6.04e-05 | 181 | 85 | 6 | CID000005192 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 6.42e-05 | 183 | 85 | 6 | 1074_UP | |
| Drug | CPG-oligonucleotide | 6.62e-05 | 184 | 85 | 6 | ctd:C408982 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 6.82e-05 | 185 | 85 | 6 | 6945_UP | |
| Drug | ferric oxide | 7.02e-05 | 186 | 85 | 6 | ctd:C000499 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 7.02e-05 | 186 | 85 | 6 | 6953_UP | |
| Drug | catechin; Up 200; 11uM; MCF7; HT_HG-U133A_EA | 8.86e-05 | 194 | 85 | 6 | 1101_UP | |
| Drug | Nadide [53-84-9]; Up 200; 6uM; HL60; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 2529_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 3237_DN | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 4366_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 3995_UP | |
| Drug | Demecolcine | H2BC12L H2BC4 H2BC21 BRCA2 CD80 HECTD4 H2BC5 H2BC3 SCAF11 NABP1 H2BC12 PTGR3 | 9.92e-05 | 878 | 85 | 12 | ctd:D003703 |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 5725_DN | |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 4628_UP | |
| Drug | Flurbiprofen [5104-49-4]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 6472_UP | |
| Drug | imiquimod | 1.16e-04 | 67 | 85 | 4 | ctd:C056493 | |
| Disease | Breast Cancer, Familial | 2.52e-08 | 30 | 86 | 5 | C0346153 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.08e-07 | 45 | 86 | 5 | DOID:3748 (is_implicated_in) | |
| Disease | Adult only | 4.75e-07 | 6 | 86 | 3 | C3842001 | |
| Disease | Todd Paralysis | 1.98e-06 | 9 | 86 | 3 | C0234544 | |
| Disease | Paralysed | 1.98e-06 | 9 | 86 | 3 | C0522224 | |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 8.40e-06 | 2 | 86 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 8.40e-06 | 2 | 86 | 2 | C4749652 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 8.50e-06 | 14 | 86 | 3 | C0677776 | |
| Disease | BREAST CANCER | 3.06e-05 | 21 | 86 | 3 | 114480 | |
| Disease | Carcinoma of lung | 4.06e-05 | 23 | 86 | 3 | C0684249 | |
| Disease | Hereditary breast ovarian cancer syndrome | 5.02e-05 | 4 | 86 | 2 | cv:C0677776 | |
| Disease | breast cancer (implicated_via_orthology) | 5.25e-05 | 25 | 86 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | Malignant tumor of breast | 6.65e-05 | 27 | 86 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 6.65e-05 | 27 | 86 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 6.65e-05 | 27 | 86 | 3 | cv:C0346153 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 8.27e-05 | 29 | 86 | 3 | C0496920 | |
| Disease | glutamate measurement | 8.27e-05 | 29 | 86 | 3 | EFO_0010487 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 8.35e-05 | 5 | 86 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | Menkes disease (implicated_via_orthology) | 8.35e-05 | 5 | 86 | 2 | DOID:1838 (implicated_via_orthology) | |
| Disease | Ovarian Carcinoma | 9.17e-05 | 30 | 86 | 3 | C0029925 | |
| Disease | colon cancer (is_implicated_in) | 1.59e-04 | 36 | 86 | 3 | DOID:219 (is_implicated_in) | |
| Disease | Inguinal hernia | 1.97e-04 | 287 | 86 | 6 | HP_0000023 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 2.98e-04 | 9 | 86 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | Pancreatic carcinoma, familial | 2.98e-04 | 9 | 86 | 2 | C2931038 | |
| Disease | Fanconi anemia (is_implicated_in) | 3.72e-04 | 10 | 86 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | Epithelioid Cell Uveal Melanoma | 4.54e-04 | 11 | 86 | 2 | EFO_1000244 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 5.44e-04 | 12 | 86 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | ovarian cancer (is_implicated_in) | 5.93e-04 | 56 | 86 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | complement component C6 measurement | 6.41e-04 | 13 | 86 | 2 | EFO_0020281 | |
| Disease | Benign tumor of pancreas | 6.41e-04 | 13 | 86 | 2 | C0347284 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 6.41e-04 | 13 | 86 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | ovarian neoplasm | 6.47e-04 | 134 | 86 | 4 | C0919267 | |
| Disease | colon cancer (is_marker_for) | 6.91e-04 | 59 | 86 | 3 | DOID:219 (is_marker_for) | |
| Disease | Malignant neoplasm of ovary | 7.03e-04 | 137 | 86 | 4 | C1140680 | |
| Disease | Hypothermia, natural | 7.47e-04 | 14 | 86 | 2 | C0020672 | |
| Disease | Mental Depression | 8.97e-04 | 254 | 86 | 5 | C0011570 | |
| Disease | insomnia, total blood protein measurement | 9.38e-04 | 148 | 86 | 4 | EFO_0004536, EFO_0004698 | |
| Disease | diet measurement | 9.48e-04 | 1049 | 86 | 10 | EFO_0008111 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.00e-03 | 67 | 86 | 3 | C3463824 | |
| Disease | Colonic Neoplasms | 1.04e-03 | 152 | 86 | 4 | C0009375 | |
| Disease | Cannabis Dependence | 1.11e-03 | 17 | 86 | 2 | C0006870 | |
| Disease | Malignant neoplasm of breast | KDM3A NRG1 H2BC4 BRCA1 BRCA2 ACO2 ZNF644 FAM217B H2BC12 RAD54L | 1.13e-03 | 1074 | 86 | 10 | C0006142 |
| Disease | Malignant tumor of colon | 1.22e-03 | 159 | 86 | 4 | C0007102 | |
| Disease | Pancreatic carcinoma | 1.39e-03 | 19 | 86 | 2 | C0235974 | |
| Disease | Adenocarcinoma of prostate | 1.54e-03 | 20 | 86 | 2 | C0007112 | |
| Disease | Depressive disorder | 1.59e-03 | 289 | 86 | 5 | C0011581 | |
| Disease | Hirschsprung disease | 1.70e-03 | 21 | 86 | 2 | MONDO_0018309 | |
| Disease | Nerve Degeneration | 1.86e-03 | 83 | 86 | 3 | C0027746 | |
| Disease | Etat Marbre | 2.04e-03 | 23 | 86 | 2 | C0266487 | |
| Disease | Glioma | 2.12e-03 | 87 | 86 | 3 | C0017638 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.22e-03 | 24 | 86 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | Neoplasm of the genitourinary tract | 2.22e-03 | 24 | 86 | 2 | cv:C0042065 | |
| Disease | Fanconi Anemia | 2.41e-03 | 25 | 86 | 2 | C0015625 | |
| Disease | autism spectrum disorder, schizophrenia | 2.71e-03 | 327 | 86 | 5 | EFO_0003756, MONDO_0005090 | |
| Disease | Bipolar Disorder | 2.73e-03 | 477 | 86 | 6 | C0005586 | |
| Disease | cerebrospinal fluid biomarker measurement | 2.81e-03 | 96 | 86 | 3 | EFO_0006794 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITKNVHTVSVEKCSE | 1091 | Q9BXT4 | |
| IKVKGKCTTDHISAA | 586 | Q99798 | |
| AKVKATTSLCESELH | 306 | A9YTQ3 | |
| VTTSGDHKAKVFCVQ | 416 | Q13685 | |
| HTVAKETCSEKSTNL | 151 | P05067 | |
| IIGVKFHVSSACKES | 191 | O14977 | |
| TICTSIVAEDKKGHL | 141 | Q13510 | |
| FCSGVIHVTKEVKEV | 31 | P33681 | |
| ELAKHAVSEGTKAVT | 106 | P57053 | |
| ITCIHKSDHSVVSDK | 871 | P59510 | |
| TCHSCTSTIEGKIGK | 181 | Q04656 | |
| KIESGKTSVVVHCSD | 426 | Q13613 | |
| TKHGEKVSLSSKCAE | 121 | Q92878 | |
| SHKKALSSCVVDEEQ | 636 | Q92698 | |
| ELAKHAVSEGTKAVT | 106 | Q16778 | |
| ELAKHAVSEGTKAVT | 106 | Q5QNW6 | |
| ELAKHAVSEGTKAVT | 106 | P06899 | |
| ELAKHAVSEGTKAVT | 106 | Q99877 | |
| TSTTGTSHLVKCAEK | 171 | Q02297 | |
| DSSTEACSVSKEKHI | 796 | Q8N7Z5 | |
| VKTDDVCVTKSHRTF | 326 | Q8N3A8 | |
| ELAKHAVSEGTKAVT | 106 | Q99879 | |
| ELAKHAVSEGTKAVT | 106 | P58876 | |
| ELAKHAVSEGTKAVT | 106 | Q93079 | |
| ELAKHAVSEGTKAVT | 106 | O60814 | |
| SCNGDTHRTKSIKEE | 721 | O43593 | |
| EGKSKAISTCTTHII | 231 | Q8IXE1 | |
| KAEKISECVQSDTHT | 331 | O60658 | |
| AESCGHATVSSEKKL | 356 | Q9NTX9 | |
| DKTSLECLKVLTGHT | 266 | Q9UKB1 | |
| AKDICATKVETEETH | 656 | Q96Q89 | |
| HEDITKDKTSTVEAC | 71 | P29459 | |
| QKTECGSHTKEETKT | 201 | Q6PEW0 | |
| TPACKSASETKVISH | 1081 | Q9Y4D8 | |
| SVSTKCHETGLLTIK | 1626 | Q6R327 | |
| DKVCTESGVTSDHLK | 836 | O95248 | |
| ICKSERVHSKSVESN | 441 | P38398 | |
| ELAKHAVSEGTKAVT | 106 | P33778 | |
| ELAKHAVSEGTKAVT | 106 | P62807 | |
| ITESKCVTILHKGFS | 81 | Q01344 | |
| ELAKHAVSEGTKAVT | 106 | Q8N257 | |
| VSHTDVTKKDLKVCV | 51 | Q9Y4C1 | |
| IASGKIVCVSHETIK | 1846 | P51587 | |
| SSRDLSKHVKVVCDG | 576 | O75912 | |
| ELAKHAVSEGTKAVT | 106 | Q99880 | |
| ELAKHAVSEGTKAVT | 106 | P23527 | |
| GTFTICHKTEVVKNT | 181 | Q8IYJ1 | |
| SETFSATCKKLHESV | 626 | Q9Y6T7 | |
| SVHRAAESCIKSTVK | 441 | P21554 | |
| VECIHEAESTTEKGK | 1481 | Q99698 | |
| SCRVTHEGSTVEKTV | 86 | A0M8Q6 | |
| DGHTEVCEIKKSASE | 916 | D6RIA3 | |
| TLSSRHIDVCSKTKE | 381 | Q9UHW9 | |
| VCHSKSGEVNSTKVA | 1416 | Q99590 | |
| GSFTICHKTEVVKNT | 191 | Q86YQ8 | |
| HSAEVIKKALSTCVS | 226 | Q8NGL9 | |
| GACKVHLVKSTSDVS | 1006 | Q6ZRI0 | |
| KTITSGIHCALEIAK | 726 | P0C7P3 | |
| EVRSCKVADKTGSIT | 41 | Q96AH0 | |
| SEHQEICIKSGKISS | 1371 | Q8WUY3 | |
| KCGAHPTSDKETSVA | 211 | O60260 | |
| SVKGKKSCHTAVDRT | 471 | P02788 | |
| SSHVTIDTLKGVKSC | 116 | P08582 | |
| SCDSGIIEDVKKTTH | 356 | A2VDJ0 | |
| LKETEKITVCGDTHG | 231 | P53041 | |
| AHVTITTKTADGKCA | 111 | P40692 | |
| SCSSLAVVEKNHTEK | 251 | Q8IW36 | |
| CSSTLKTHKIIHTGE | 336 | P0CB33 | |
| ETKKSSGEITHTLSC | 526 | Q9Y2W6 | |
| ADKVSSGKSSVLVHC | 361 | Q13496 | |
| GVKQLKSEEHCIVTE | 86 | Q8WU10 | |
| EKHTDTDVLEACSKT | 621 | Q8N3U4 | |
| AKEKIEGCHICTSVT | 21 | Q7Z4S6 | |
| HEVRTCKVADKTGSI | 36 | Q9BQ15 | |
| TSVKVCSVKERHASE | 236 | P49754 | |
| AKCHVIGTCSSDEKS | 196 | Q8N4Q0 | |
| RKAIEKSETTSEHTC | 1026 | Q9H582 | |
| ECGKTFIKVSTLTTH | 641 | O43345 | |
| GSTEHEITKCKAKVD | 161 | Q8N567 | |
| HSETVKIGKVDCTQH | 236 | Q8NBS9 | |
| EHKVTHSKSLDTGTC | 976 | Q2M1K9 | |
| QKCHSIGETDEVTKT | 181 | O15535 | |
| ICIKTHESGQKEIEA | 396 | Q2TBF2 | |
| CIGHTKAKTDVLISV | 1256 | Q9BXT5 | |
| KITCEEKATESHSTS | 111 | Q7Z3V5 | |
| CKSHLETGTKDQETV | 1411 | Q96QT4 | |
| EKKVHSERSAESCAT | 361 | Q86Y07 | |
| KTCFRKIGDSSVETH | 411 | Q5H9K5 |